Status:
COMPLETED
SALTO - Epidemiological Study on Compliance and Treatment Satisfaction
Lead Sponsor:
Bayer
Conditions:
Thromboembolism
Eligibility:
All Genders
18+ years
Brief Summary
Patients that are on total knee/hip replacement initiate prophylaxis treatment on the hospital ground. Once they leave the hospital, as outpatients they continue with the treatment at least during two...
Eligibility Criteria
Inclusion
- Patients in antithrombotic prophylaxis treatment after total knee/hip replacement. This is an epidemiological study where the patients to be included will be those that are treated with antithrombotics as out-patients in real life conditions.
Exclusion
- Patients who has been previously treated with injectable antithrombotic treatments.
- Diabetic patients treated with insulin.
- Patients who do not sign Informed Consent Form.
Key Trial Info
Start Date :
November 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2009
Estimated Enrollment :
480 Patients enrolled
Trial Details
Trial ID
NCT00911001
Start Date
November 1 2008
End Date
March 1 2009
Last Update
September 19 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations, Spain